home / stock / pdsb / pdsb articles

PDSB Articles, PDS Biotechnology Corporation

Stock Information
Company Name: PDS Biotechnology Corporation
Stock Symbol: PDSB
Market: NYSE
Website: pdsbiotech.com
Menu
PDSB PDSB Quote PDSB Short PDSB News PDSB Articles PDSB Message Board
Get PDSB Alerts

News, Short Squeeze, Breakout and More Instantly...
PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer | Benzinga

PRINCETON, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or "the Company"), a clinical-stag...
PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference | Benzinga

PRINCETON, N.J., Jan. 16, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or "the Company"), a clinical-stag...

PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Benzinga

PRINCETON, N.J., Dec. 04, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or "Company"), a clinical-stage im...

PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer | Benzinga

PRINCETON, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or the "Company"), a clinical-stag...
PDS Biotechnology Announces Conference Call and Webcast for Third Quarter 2023 Financial Results | Benzinga

PRINCETON, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) (PDS Biotech or the Company), a clinical-stage im...

PDS Biotech to Present at the LD Micro Main Event XVI | Benzinga

PRINCETON, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) (PDS Biotech or the Company), a clinical-stage i...

PDS Biotech to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference | Benzinga

PRINCETON, N.J., Sept. 20, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) (PDS Biotech or the Company), a clinical-stage i...
PDS Biotech to Host Key Opinion Leader Roundtable Addressing Current and Future Treatments for Recurrent/Metastatic HPV-Positive HNSCC and the Potential Application of PDS0101 on September 27, 2023 | Benzinga

PRINCETON, N.J., Sept. 13, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) (PDS Biotech or Company), a clinical-stage immun...

PDS Biotech to Participate at the H.C. Wainwright 25th Annual Global Investment Conference | Benzinga

PRINCETON, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB) (PDS Biotech or the Company), a clinical-stage i...

Next 10